In parallel to biomarker identification, we developed and optimized a duplex antibody array for the two serum markers used in the first trimester combined test for DS, namely, pregnancy-associated plasma protein-A (PAPP-A) and the free beta subunit of human chorionic gonadotropin (fβ-hCG). The gene discussed is PAPPA; the disease is Dravet syndrome.